| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | RNA polymerase II sequence-specific DNA-binding transcription factor recruiting activity | 2.08e-06 | 4 | 162 | 3 | GO:0001010 | |
| GeneOntologyMolecularFunction | extracellular matrix constituent, lubricant activity | 2.08e-06 | 4 | 162 | 3 | GO:0030197 | |
| GeneOntologyMolecularFunction | transcription factor binding | DCAF1 NANOGP8 ZBTB16 FOXP2 PPRC1 NANOG PCLO MED1 CREB1 CRY2 STRN BRD8 NANOGP1 PER2 MYOCD BSN NFAT5 NOTCH2 | 4.17e-05 | 753 | 162 | 18 | GO:0008134 |
| GeneOntologyMolecularFunction | amino acid sensor activity | 6.54e-05 | 2 | 162 | 2 | GO:0140785 | |
| GeneOntologyMolecularFunction | histone acetyltransferase binding | 8.46e-05 | 29 | 162 | 4 | GO:0035035 | |
| GeneOntologyMolecularFunction | transcription coregulator binding | 1.48e-04 | 140 | 162 | 7 | GO:0001221 | |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | KLF11 NANOGP8 ZBTB16 FOXP2 ZNF460 NANOG HLF ZNF316 RFX6 MED1 CREB1 HSF5 STAT4 FOSL1 SALL2 NANOGP1 PER2 GLI3 EHF NFAT5 TCF7L1 NOTCH2 NPAS2 | 2.47e-04 | 1271 | 162 | 23 | GO:0000987 |
| GeneOntologyMolecularFunction | phosphatase binding | 3.14e-04 | 264 | 162 | 9 | GO:0019902 | |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | KLF11 NANOGP8 ZBTB16 FOXP2 ZNF460 NANOG HLF ZNF316 RFX6 MED1 CREB1 HSF5 STAT4 FOSL1 SALL2 NANOGP1 PER2 GLI3 EHF NFAT5 TCF7L1 NPAS2 | 4.66e-04 | 1244 | 162 | 22 | GO:0000978 |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | NANOGP8 ZBTB16 NANOG HLF RFX6 CREB1 STAT4 FOSL1 SALL2 NANOGP1 EHF NFAT5 NOTCH2 | 6.65e-04 | 560 | 162 | 13 | GO:0001228 |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | NANOGP8 ZBTB16 NANOG HLF RFX6 CREB1 STAT4 FOSL1 SALL2 NANOGP1 EHF NFAT5 NOTCH2 | 7.34e-04 | 566 | 162 | 13 | GO:0001216 |
| GeneOntologyMolecularFunction | transcription coactivator activity | 8.45e-04 | 303 | 162 | 9 | GO:0003713 | |
| GeneOntologyMolecularFunction | nuclear receptor binding | 8.50e-04 | 187 | 162 | 7 | GO:0016922 | |
| GeneOntologyMolecularFunction | transcription corepressor binding | 1.34e-03 | 59 | 162 | 4 | GO:0001222 | |
| GeneOntologyMolecularFunction | modification-dependent protein binding | 1.49e-03 | 206 | 162 | 7 | GO:0140030 | |
| GeneOntologyMolecularFunction | hyaluronic acid binding | 1.64e-03 | 29 | 162 | 3 | GO:0005540 | |
| GeneOntologyMolecularFunction | structural constituent of presynaptic active zone | 1.77e-03 | 8 | 162 | 2 | GO:0098882 | |
| GeneOntologyMolecularFunction | lysine-acetylated histone binding | 1.81e-03 | 30 | 162 | 3 | GO:0070577 | |
| GeneOntologyMolecularFunction | actin binding | SHROOM3 SPATA31A3 SPATA31A7 COBLL1 TRIOBP SPATA31A5 SPATA31A1 CLMN PHACTR4 TNS4 MRTFA | 1.88e-03 | 479 | 162 | 11 | GO:0003779 |
| GeneOntologyMolecularFunction | acetylation-dependent protein binding | 1.99e-03 | 31 | 162 | 3 | GO:0140033 | |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | 2.20e-03 | 417 | 162 | 10 | GO:0061629 | |
| GeneOntologyBiologicalProcess | negative regulation of endodermal cell fate specification | 1.75e-06 | 4 | 158 | 3 | GO:0042664 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle | KLF11 CACNB4 NANOGP8 TBRG4 CEP85 USP28 DBF4B NANOG APC CEP192 CUL7 MED1 KMT2E INO80D HEXIM2 FOSL1 PPP1R10 BRD8 NANOGP1 PER2 ABRAXAS1 PHACTR4 PKD1 NFRKB CDK5RAP1 MYOCD | 3.35e-06 | 1256 | 158 | 26 | GO:0051726 |
| GeneOntologyBiologicalProcess | regulation of endodermal cell fate specification | 4.36e-06 | 5 | 158 | 3 | GO:0042663 | |
| GeneOntologyBiologicalProcess | negative regulation of endodermal cell differentiation | 8.67e-06 | 6 | 158 | 3 | GO:1903225 | |
| GeneOntologyBiologicalProcess | negative regulation of cell fate specification | 2.40e-05 | 8 | 158 | 3 | GO:0009996 | |
| GeneOntologyBiologicalProcess | regulation of endodermal cell differentiation | 5.09e-05 | 10 | 158 | 3 | GO:1903224 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | NANOGP8 ZBTB16 PPRC1 NANOG HLF RFX6 PHF8 MED1 CREB1 STAT4 FOSL1 KMT2C BRD8 SALL2 NANOGP1 GLI3 EHF PKD1 IRF2BPL MYOCD NFAT5 TCF7L1 NOTCH2 MRTFA NPAS2 | 5.63e-05 | 1390 | 158 | 25 | GO:0045944 |
| GeneOntologyBiologicalProcess | negative regulation of cyclin-dependent protein serine/threonine kinase activity | 6.78e-05 | 29 | 158 | 4 | GO:0045736 | |
| GeneOntologyBiologicalProcess | endodermal cell fate specification | 6.96e-05 | 11 | 158 | 3 | GO:0001714 | |
| GeneOntologyBiologicalProcess | negative regulation of cyclin-dependent protein kinase activity | 7.78e-05 | 30 | 158 | 4 | GO:1904030 | |
| GeneOntologyBiologicalProcess | presynapse to nucleus signaling pathway | 1.74e-04 | 3 | 158 | 2 | GO:0099526 | |
| GeneOntologyBiologicalProcess | cell dedifferentiation | 1.88e-04 | 15 | 158 | 3 | GO:0043697 | |
| GeneOntologyBiologicalProcess | dedifferentiation | 1.88e-04 | 15 | 158 | 3 | GO:0043696 | |
| GeneOntologyBiologicalProcess | tissue morphogenesis | FAT4 SHROOM3 NANOGP8 RPGRIP1L NANOG APC MED1 TGFBR3 NANOGP1 MEGF8 GLI3 PHACTR4 PKD1 TCF7L1 NOTCH2 MRTFA | 2.15e-04 | 750 | 158 | 16 | GO:0048729 |
| GeneOntologyBiologicalProcess | negative regulation of cell fate commitment | 2.77e-04 | 17 | 158 | 3 | GO:0010454 | |
| GeneOntologyBiologicalProcess | lung alveolus development | 2.77e-04 | 75 | 158 | 5 | GO:0048286 | |
| GeneOntologyBiologicalProcess | endodermal cell fate commitment | 3.31e-04 | 18 | 158 | 3 | GO:0001711 | |
| GeneOntologyBiologicalProcess | regulation of stem cell division | 3.31e-04 | 18 | 158 | 3 | GO:2000035 | |
| GeneOntologyBiologicalProcess | eye development | RPGRIP1L MAN2A1 FOXP2 APC MED1 KMT2C SALL2 GLI3 PHACTR4 RP1 MERTK NOTCH2 | 3.37e-04 | 480 | 158 | 12 | GO:0001654 |
| GeneOntologyBiologicalProcess | presynaptic signal transduction | 3.46e-04 | 4 | 158 | 2 | GO:0098928 | |
| GeneOntologyBiologicalProcess | placenta blood vessel development | 3.54e-04 | 44 | 158 | 4 | GO:0060674 | |
| GeneOntologyBiologicalProcess | positive regulation of neuroblast proliferation | 3.54e-04 | 44 | 158 | 4 | GO:0002052 | |
| GeneOntologyBiologicalProcess | visual system development | RPGRIP1L MAN2A1 FOXP2 APC MED1 KMT2C SALL2 GLI3 PHACTR4 RP1 MERTK NOTCH2 | 3.57e-04 | 483 | 158 | 12 | GO:0150063 |
| GeneOntologyCellularComponent | Golgi lumen | 2.07e-07 | 109 | 165 | 9 | GO:0005796 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | DCAF1 DBF4B HLF NUP98 CUL7 MED1 KMT2E CREB1 INO80D STAT4 HELB FOSL1 CRY2 KMT2C BRD8 R3HCC1L PER2 POLR3E CLMN ABRAXAS1 NFRKB MYOCD HDAC10 TCF7L1 NPAS2 | 8.07e-05 | 1377 | 165 | 25 | GO:0140513 |
| GeneOntologyCellularComponent | Cry-Per complex | 1.85e-04 | 3 | 165 | 2 | GO:1990512 | |
| Domain | DUF4599 | 3.48e-08 | 12 | 162 | 5 | PF15371 | |
| Domain | DUF4599 | 3.48e-08 | 12 | 162 | 5 | IPR027970 | |
| Domain | SEA | 1.37e-06 | 23 | 162 | 5 | PS50024 | |
| Domain | SEA_dom | 1.37e-06 | 23 | 162 | 5 | IPR000082 | |
| Domain | LRRC37AB_C | 2.55e-06 | 4 | 162 | 3 | IPR029423 | |
| Domain | LRRC37AB_C | 2.55e-06 | 4 | 162 | 3 | PF14914 | |
| Domain | LRRC37_N | 2.55e-06 | 4 | 162 | 3 | IPR032754 | |
| Domain | LRRC37 | 2.55e-06 | 4 | 162 | 3 | PF15779 | |
| Domain | LRRC37A/B-like | 2.55e-06 | 4 | 162 | 3 | IPR015753 | |
| Domain | SEA | 5.10e-06 | 14 | 162 | 4 | SM00200 | |
| Domain | EGF_1 | FAT4 MUC3B ZAN MUC12 MEGF8 MUC17 VCAN NCAN MUC3A MUC4 NOTCH2 | 1.44e-05 | 255 | 162 | 11 | PS00022 |
| Domain | EGF-like_CS | FAT4 MUC3B ZAN MUC12 MEGF8 MUC17 VCAN NCAN MUC3A MUC4 NOTCH2 | 1.79e-05 | 261 | 162 | 11 | IPR013032 |
| Domain | EGF_2 | FAT4 MUC3B ZAN MUC12 MEGF8 MUC17 VCAN NCAN MUC3A MUC4 NOTCH2 | 2.06e-05 | 265 | 162 | 11 | PS01186 |
| Domain | RPEL | 2.19e-05 | 7 | 162 | 3 | PS51073 | |
| Domain | RPEL | 2.19e-05 | 7 | 162 | 3 | SM00707 | |
| Domain | RPEL | 2.19e-05 | 7 | 162 | 3 | PF02755 | |
| Domain | RPEL_repeat | 2.19e-05 | 7 | 162 | 3 | IPR004018 | |
| Domain | SEA | 3.53e-05 | 22 | 162 | 4 | PF01390 | |
| Domain | EGF | 4.00e-05 | 235 | 162 | 10 | SM00181 | |
| Domain | EGF_3 | 4.00e-05 | 235 | 162 | 10 | PS50026 | |
| Domain | EGF-like_dom | 6.51e-05 | 249 | 162 | 10 | IPR000742 | |
| Domain | SAR1 | 7.48e-05 | 2 | 162 | 2 | PS51422 | |
| Domain | Znf_piccolo | 7.48e-05 | 2 | 162 | 2 | IPR008899 | |
| Domain | Small_GTPase_SAR1 | 7.48e-05 | 2 | 162 | 2 | IPR006687 | |
| Domain | zf-piccolo | 7.48e-05 | 2 | 162 | 2 | PF05715 | |
| Domain | Link_dom | 1.72e-04 | 13 | 162 | 3 | IPR000538 | |
| Domain | Xlink | 1.72e-04 | 13 | 162 | 3 | PF00193 | |
| Domain | LINK_2 | 1.72e-04 | 13 | 162 | 3 | PS50963 | |
| Domain | LINK | 1.72e-04 | 13 | 162 | 3 | SM00445 | |
| Domain | LINK_1 | 1.72e-04 | 13 | 162 | 3 | PS01241 | |
| Domain | Znf_FYVE_PHD | 2.99e-04 | 147 | 162 | 7 | IPR011011 | |
| Domain | VWF_type-D | 3.30e-04 | 16 | 162 | 3 | IPR001846 | |
| Domain | VWFD | 3.30e-04 | 16 | 162 | 3 | PS51233 | |
| Domain | VWD | 3.30e-04 | 16 | 162 | 3 | SM00216 | |
| Domain | VWD | 3.30e-04 | 16 | 162 | 3 | PF00094 | |
| Domain | PHD | 4.88e-04 | 75 | 162 | 5 | PF00628 | |
| Domain | Znf_PHD-finger | 6.20e-04 | 79 | 162 | 5 | IPR019787 | |
| Domain | Znf_RING/FYVE/PHD | SH3RF1 RNF19A BAZ2B RC3H1 PCLO PHF8 KMT2E TRIM66 KMT2C USP5 IRF2BPL BSN | 6.80e-04 | 459 | 162 | 12 | IPR013083 |
| Domain | PHD | 1.07e-03 | 89 | 162 | 5 | SM00249 | |
| Domain | Znf_PHD | 1.18e-03 | 91 | 162 | 5 | IPR001965 | |
| Domain | ZF_PHD_2 | 1.43e-03 | 95 | 162 | 5 | PS50016 | |
| Domain | ZF_PHD_1 | 1.49e-03 | 96 | 162 | 5 | PS01359 | |
| Domain | EGF_Ca-bd_CS | 1.57e-03 | 97 | 162 | 5 | IPR018097 | |
| Domain | EGF_CA | 1.71e-03 | 99 | 162 | 5 | PS01187 | |
| Domain | ASX_HYDROXYL | 1.79e-03 | 100 | 162 | 5 | PS00010 | |
| Domain | - | SH3RF1 RNF19A BAZ2B RC3H1 PCLO PHF8 KMT2E TRIM66 KMT2C USP5 BSN | 1.90e-03 | 449 | 162 | 11 | 3.30.40.10 |
| Pathway | REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC | 1.11e-09 | 16 | 105 | 6 | M27410 | |
| Pathway | REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS | 1.71e-09 | 17 | 105 | 6 | M27412 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 1.35e-08 | 23 | 105 | 6 | M556 | |
| Pathway | REACTOME_DECTIN_2_FAMILY | 3.02e-08 | 26 | 105 | 6 | M27483 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 6.94e-07 | 68 | 105 | 7 | M27303 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 1.16e-06 | 143 | 105 | 9 | M27275 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | 6.48e-06 | 62 | 105 | 6 | M546 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 1.58e-05 | 21 | 105 | 4 | MM15706 | |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | 1.03e-04 | 250 | 105 | 9 | M27554 | |
| Pathway | WP_WNT_SIGNALING_PATHWAY_AND_PLURIPOTENCY | 1.06e-04 | 101 | 105 | 6 | MM15829 | |
| Pathway | KEGG_CIRCADIAN_RHYTHM_MAMMAL | 1.09e-04 | 13 | 105 | 3 | M18009 | |
| Pathway | REACTOME_CIRCADIAN_CLOCK | 1.72e-04 | 70 | 105 | 5 | M938 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 1.78e-04 | 111 | 105 | 6 | M27416 | |
| Pathway | PID_CIRCADIAN_PATHWAY | 2.10e-04 | 16 | 105 | 3 | M95 | |
| Pathway | WP_GDNFRET_SIGNALING_AXIS | 5.58e-04 | 22 | 105 | 3 | MM15887 | |
| Pathway | REACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS | 6.20e-04 | 140 | 105 | 6 | M27484 | |
| Pathway | WP_GDNFRET_SIGNALING_AXIS | 6.38e-04 | 23 | 105 | 3 | M39814 | |
| Pathway | WP_ECTODERM_DIFFERENTIATION | 6.68e-04 | 142 | 105 | 6 | M39575 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | ARHGAP32 SHROOM3 ZBTB16 SH3RF1 DSC2 COBLL1 RAB11FIP2 CKAP5 APC CEP192 GIGYF1 KIAA1191 INPP5F LYST TRAK1 ZNF106 MEGF8 CLMN N4BP2 PHACTR4 NAV2 NOTCH2 AGAP3 | 3.49e-11 | 861 | 168 | 23 | 36931259 |
| Pubmed | Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux. | 2.05e-10 | 18 | 168 | 6 | 18834073 | |
| Pubmed | Repression of Nanog gene transcription by Tcf3 limits embryonic stem cell self-renewal. | 5.25e-10 | 4 | 168 | 4 | 16894029 | |
| Pubmed | 7.82e-09 | 6 | 168 | 4 | 20850414 | ||
| Pubmed | 7.82e-09 | 6 | 168 | 4 | 18467660 | ||
| Pubmed | The Pluripotency Factor NANOG Binds to GLI Proteins and Represses Hedgehog-mediated Transcription. | 7.82e-09 | 6 | 168 | 4 | 26797124 | |
| Pubmed | Targeted disruption of the spermatid-specific gene Spata31 causes male infertility. | 7.82e-09 | 6 | 168 | 4 | 25930072 | |
| Pubmed | 7.82e-09 | 6 | 168 | 4 | 36869101 | ||
| Pubmed | The pluripotency factor NANOG controls primitive hematopoiesis and directly regulates Tal1. | 1.11e-07 | 3 | 168 | 3 | 30814124 | |
| Pubmed | Multiple phases in regulation of Nanog expression during pre-implantation development. | 1.11e-07 | 3 | 168 | 3 | 26660234 | |
| Pubmed | Crystal structure and DNA binding of the homeodomain of the stem cell transcription factor Nanog. | 1.11e-07 | 3 | 168 | 3 | 18177668 | |
| Pubmed | 1.11e-07 | 3 | 168 | 3 | 24929238 | ||
| Pubmed | Nanog and transcriptional networks in embryonic stem cell pluripotency. | 1.11e-07 | 3 | 168 | 3 | 17211451 | |
| Pubmed | 1.11e-07 | 3 | 168 | 3 | 15502159 | ||
| Pubmed | 1.11e-07 | 3 | 168 | 3 | 20574542 | ||
| Pubmed | lincRNAs act in the circuitry controlling pluripotency and differentiation. | 1.11e-07 | 3 | 168 | 3 | 21874018 | |
| Pubmed | Cell signalling regulates dynamics of Nanog distribution in embryonic stem cell populations. | 1.11e-07 | 3 | 168 | 3 | 23054952 | |
| Pubmed | CrxOS maintains the self-renewal capacity of murine embryonic stem cells. | 1.11e-07 | 3 | 168 | 3 | 19800316 | |
| Pubmed | Selenium Augments microRNA Directed Reprogramming of Fibroblasts to Cardiomyocytes via Nanog. | 1.11e-07 | 3 | 168 | 3 | 26975336 | |
| Pubmed | Nanog suppresses cell migration by downregulating thymosin β4 and Rnd3. | 1.11e-07 | 3 | 168 | 3 | 23329853 | |
| Pubmed | 1.11e-07 | 3 | 168 | 3 | 23665121 | ||
| Pubmed | Ectopic overexpression of Nanog induces tumorigenesis in non-tumorous fibroblasts. | 1.11e-07 | 3 | 168 | 3 | 26733157 | |
| Pubmed | 1.11e-07 | 3 | 168 | 3 | 16501172 | ||
| Pubmed | Regulated fluctuations in nanog expression mediate cell fate decisions in embryonic stem cells. | 1.11e-07 | 3 | 168 | 3 | 19582141 | |
| Pubmed | 1.11e-07 | 3 | 168 | 3 | 19703398 | ||
| Pubmed | Nanog Fluctuations in Embryonic Stem Cells Highlight the Problem of Measurement in Cell Biology. | 1.11e-07 | 3 | 168 | 3 | 28636920 | |
| Pubmed | 1.11e-07 | 3 | 168 | 3 | 20539761 | ||
| Pubmed | 1.11e-07 | 3 | 168 | 3 | 18584034 | ||
| Pubmed | 1.11e-07 | 3 | 168 | 3 | 21969378 | ||
| Pubmed | 1.11e-07 | 3 | 168 | 3 | 20661723 | ||
| Pubmed | 1.11e-07 | 3 | 168 | 3 | 29245050 | ||
| Pubmed | 1.11e-07 | 3 | 168 | 3 | 10512748 | ||
| Pubmed | Aggregation of embryonic stem cells induces Nanog repression and primitive endoderm differentiation. | 1.11e-07 | 3 | 168 | 3 | 15494369 | |
| Pubmed | Identification of two distinct transactivation domains in the pluripotency sustaining factor nanog. | 1.11e-07 | 3 | 168 | 3 | 14728807 | |
| Pubmed | Nanog overcomes reprogramming barriers and induces pluripotency in minimal conditions. | 1.11e-07 | 3 | 168 | 3 | 21194951 | |
| Pubmed | 1.11e-07 | 3 | 168 | 3 | 22388986 | ||
| Pubmed | 1.11e-07 | 3 | 168 | 3 | 16791199 | ||
| Pubmed | Heparan sulfate regulates self-renewal and pluripotency of embryonic stem cells. | 1.11e-07 | 3 | 168 | 3 | 18024963 | |
| Pubmed | 1.11e-07 | 3 | 168 | 3 | 27125671 | ||
| Pubmed | Stochastic promoter activation affects Nanog expression variability in mouse embryonic stem cells. | 1.11e-07 | 3 | 168 | 3 | 25410303 | |
| Pubmed | 1.11e-07 | 3 | 168 | 3 | 33334884 | ||
| Pubmed | Forced expression of Nanog in hematopoietic stem cells results in a gammadeltaT-cell disorder. | 1.11e-07 | 3 | 168 | 3 | 17360937 | |
| Pubmed | 1.11e-07 | 3 | 168 | 3 | 26760119 | ||
| Pubmed | Nanog is dispensable for the generation of induced pluripotent stem cells. | 1.11e-07 | 3 | 168 | 3 | 24461999 | |
| Pubmed | Locating and Characterizing a Transgene Integration Site by Nanopore Sequencing. | 1.11e-07 | 3 | 168 | 3 | 30837263 | |
| Pubmed | 1.11e-07 | 3 | 168 | 3 | 25173648 | ||
| Pubmed | Distinct Contributions of Tryptophan Residues within the Dimerization Domain to Nanog Function. | 1.11e-07 | 3 | 168 | 3 | 27939294 | |
| Pubmed | 1.11e-07 | 3 | 168 | 3 | 18442017 | ||
| Pubmed | 1.11e-07 | 3 | 168 | 3 | 16790525 | ||
| Pubmed | Primitive endoderm differentiates via a three-step mechanism involving Nanog and RTK signaling. | 1.11e-07 | 3 | 168 | 3 | 22172669 | |
| Pubmed | 1.11e-07 | 3 | 168 | 3 | 19447925 | ||
| Pubmed | The molecular logic of Nanog-induced self-renewal in mouse embryonic stem cells. | 1.11e-07 | 3 | 168 | 3 | 30846691 | |
| Pubmed | Generation of germline-competent induced pluripotent stem cells. | 1.11e-07 | 3 | 168 | 3 | 17554338 | |
| Pubmed | Expression of Nanog gene promotes NIH3T3 cell proliferation. | 1.11e-07 | 3 | 168 | 3 | 16259959 | |
| Pubmed | 1.11e-07 | 3 | 168 | 3 | 12609610 | ||
| Pubmed | 1.11e-07 | 3 | 168 | 3 | 24227785 | ||
| Pubmed | The pluripotency factor nanog promotes breast cancer tumorigenesis and metastasis. | 1.11e-07 | 3 | 168 | 3 | 23770853 | |
| Pubmed | Nanog-independent reprogramming to iPSCs with canonical factors. | 1.11e-07 | 3 | 168 | 3 | 24527385 | |
| Pubmed | 1.11e-07 | 3 | 168 | 3 | 18086680 | ||
| Pubmed | 1.11e-07 | 3 | 168 | 3 | 17204467 | ||
| Pubmed | 1.11e-07 | 3 | 168 | 3 | 23200040 | ||
| Pubmed | NANOG alone induces germ cells in primed epiblast in vitro by activation of enhancers. | 1.11e-07 | 3 | 168 | 3 | 26751055 | |
| Pubmed | Epigenetic regulation of Nanog gene in embryonic stem and trophoblast stem cells. | 1.11e-07 | 3 | 168 | 3 | 17352742 | |
| Pubmed | 1.11e-07 | 3 | 168 | 3 | 23178592 | ||
| Pubmed | Stochastic NANOG fluctuations allow mouse embryonic stem cells to explore pluripotency. | 1.11e-07 | 3 | 168 | 3 | 25005472 | |
| Pubmed | 1.11e-07 | 3 | 168 | 3 | 16773043 | ||
| Pubmed | 1.11e-07 | 3 | 168 | 3 | 23071603 | ||
| Pubmed | 1.11e-07 | 3 | 168 | 3 | 21119109 | ||
| Pubmed | 1.11e-07 | 3 | 168 | 3 | 32145514 | ||
| Pubmed | Nanog safeguards pluripotency and mediates germline development. | 1.11e-07 | 3 | 168 | 3 | 18097409 | |
| Pubmed | Heterogeneities in Nanog Expression Drive Stable Commitment to Pluripotency in the Mouse Blastocyst. | 1.11e-07 | 3 | 168 | 3 | 25753417 | |
| Pubmed | 1.11e-07 | 3 | 168 | 3 | 22337995 | ||
| Pubmed | 1.11e-07 | 3 | 168 | 3 | 18290762 | ||
| Pubmed | Reprogramming of mouse fibroblasts into induced pluripotent stem cells with Nanog. | 1.11e-07 | 3 | 168 | 3 | 23333380 | |
| Pubmed | 1.11e-07 | 3 | 168 | 3 | 25825768 | ||
| Pubmed | Epithelial cell senescence induces pulmonary fibrosis through Nanog-mediated fibroblast activation. | 1.11e-07 | 3 | 168 | 3 | 31891567 | |
| Pubmed | Isolation and characterization of the murine Nanog gene promoter. | 1.11e-07 | 3 | 168 | 3 | 15916719 | |
| Pubmed | Nanog retrotransposed genes with functionally conserved open reading frames. | 1.11e-07 | 3 | 168 | 3 | 16845474 | |
| Pubmed | 1.11e-07 | 3 | 168 | 3 | 16313224 | ||
| Pubmed | Effect of Nanog overexpression on the metastatic potential of a mouse melanoma cell line B16-BL6. | 1.11e-07 | 3 | 168 | 3 | 33665763 | |
| Pubmed | 1.11e-07 | 3 | 168 | 3 | 22028025 | ||
| Pubmed | Context-Dependent Functions of NANOG Phosphorylation in Pluripotency and Reprogramming. | 1.11e-07 | 3 | 168 | 3 | 28457890 | |
| Pubmed | Requirement of Nanog dimerization for stem cell self-renewal and pluripotency. | 1.11e-07 | 3 | 168 | 3 | 18436640 | |
| Pubmed | 1.11e-07 | 3 | 168 | 3 | 21499299 | ||
| Pubmed | Phosphorylation of NANOG by casein kinase I regulates embryonic stem cell self-renewal. | 1.11e-07 | 3 | 168 | 3 | 33107035 | |
| Pubmed | 1.11e-07 | 3 | 168 | 3 | 35976266 | ||
| Pubmed | 1.11e-07 | 3 | 168 | 3 | 24681518 | ||
| Pubmed | 1.11e-07 | 3 | 168 | 3 | 26549484 | ||
| Pubmed | 1.11e-07 | 3 | 168 | 3 | 21187909 | ||
| Pubmed | Functional analysis of two Sp1/Sp3 binding sites in murine Nanog gene promoter. | 1.11e-07 | 3 | 168 | 3 | 16541131 | |
| Pubmed | Role of Nanog in the maintenance of marrow stromal stem cells during post natal bone regeneration. | 1.11e-07 | 3 | 168 | 3 | 22142851 | |
| Pubmed | NANOG amplifies STAT3 activation and they synergistically induce the naive pluripotent program. | 1.11e-07 | 3 | 168 | 3 | 24462001 | |
| Pubmed | Nanog-dependent feedback loops regulate murine embryonic stem cell heterogeneity. | 1.11e-07 | 3 | 168 | 3 | 23103910 | |
| Pubmed | DCAF1 NOL4 DSC2 FOXP2 ZNF460 ATXN7L1 ZNF316 GIGYF1 CUL7 PHF8 INO80D KNOP1 TRIM66 BRD8 SALL2 GSE1 GLI3 NFRKB TCF7L1 NOTCH2 AGAP3 | 1.17e-07 | 1116 | 168 | 21 | 31753913 | |
| Pubmed | 1.69e-07 | 11 | 168 | 4 | 37012455 | ||
| Pubmed | SHROOM3 TBRG4 VPS39 USP28 HECTD4 TRIOBP INPP5F ANKLE2 GPATCH2L KMT2C SETBP1 NAV2 BSN HPS5 | 3.31e-07 | 529 | 168 | 14 | 14621295 | |
| Pubmed | 3.63e-07 | 13 | 168 | 4 | 33394034 | ||
| Pubmed | 4.41e-07 | 4 | 168 | 3 | 22315219 | ||
| Pubmed | USP21 deubiquitylates Nanog to regulate protein stability and stem cell pluripotency. | 4.41e-07 | 4 | 168 | 3 | 29263902 | |
| Pubmed | Nanog positively regulates Zfp57 expression in mouse embryonic stem cells. | 4.41e-07 | 4 | 168 | 3 | 25445595 | |
| Interaction | YWHAH interactions | ARHGAP32 SHROOM3 EPPK1 RPGRIP1L SH3RF1 DSC2 NHSL2 COBLL1 RAB11FIP2 HECTD4 CKAP5 APC CEP192 GIGYF1 KIAA1191 INPP5F MED1 LYST TRAK1 ZNF106 MEGF8 CLMN PHACTR4 NAV2 NOTCH2 AGAP3 | 5.12e-07 | 1102 | 159 | 26 | int:YWHAH |
| Interaction | YWHAE interactions | DCAF1 ARHGAP32 SHROOM3 RPGRIP1L SH3RF1 DSC2 SH2B3 RC3H1 COBLL1 RAB11FIP2 CKAP5 APC GIGYF1 INPP5F CUL7 LYST STAC TRAK1 CRY2 ZNF106 PER2 SAR1B PHACTR4 NAV2 MERTK AGAP3 | 5.71e-06 | 1256 | 159 | 26 | int:YWHAE |
| Interaction | YWHAQ interactions | ARHGAP32 SHROOM3 EPPK1 RPGRIP1L SH3RF1 DSC2 RC3H1 COBLL1 RAB11FIP2 HECTD4 APC CEP192 GIGYF1 INPP5F CUL7 MED1 LYST PDXK TRAK1 CRY2 ZNF106 PHACTR4 NAV2 MERTK | 7.49e-06 | 1118 | 159 | 24 | int:YWHAQ |
| Interaction | SYNE3 interactions | ARHGAP32 SHROOM3 CEP85 RC3H1 NUP98 APC CEP192 GIGYF1 ANKLE2 GSE1 CLMN N4BP2 GLI3 NOTCH2 | 1.19e-05 | 444 | 159 | 14 | int:SYNE3 |
| Interaction | YWHAG interactions | ARHGAP32 SHROOM3 RPGRIP1L SH3RF1 DSC2 NHSL2 RC3H1 COBLL1 RAB11FIP2 HECTD4 CKAP5 APC CEP192 GIGYF1 INPP5F CUL7 LYST TRAK1 ZNF106 CLMN N4BP2 PHACTR4 NAV2 NOTCH2 AGAP3 | 1.55e-05 | 1248 | 159 | 25 | int:YWHAG |
| Interaction | YWHAB interactions | ARHGAP32 SHROOM3 SH3RF1 DSC2 RC3H1 COBLL1 RAB11FIP2 HECTD4 APC CEP192 GIGYF1 INPP5F CUL7 LYST STAC TRAK1 ZNF106 PHACTR4 NAV2 MERTK AGAP3 | 4.97e-05 | 1014 | 159 | 21 | int:YWHAB |
| Interaction | GARRE1 interactions | 5.52e-05 | 167 | 159 | 8 | int:GARRE1 | |
| Interaction | CEP85 interactions | 6.00e-05 | 169 | 159 | 8 | int:CEP85 | |
| Interaction | CEP135 interactions | ARHGAP32 SHROOM3 CEP85 RPGRIP1L APC CEP192 GIGYF1 ANKLE2 TBC1D31 GSE1 | 6.21e-05 | 272 | 159 | 10 | int:CEP135 |
| Cytoband | 7q22 | 2.81e-07 | 38 | 168 | 5 | 7q22 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q22 | 1.76e-05 | 219 | 168 | 7 | chr7q22 | |
| Cytoband | 10q26.11 | 2.60e-05 | 16 | 168 | 3 | 10q26.11 | |
| Cytoband | 5q21-q22 | 7.95e-05 | 4 | 168 | 2 | 5q21-q22 | |
| Cytoband | 17q21.31 | 2.42e-04 | 82 | 168 | 4 | 17q21.31 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9q12 | 3.67e-04 | 8 | 168 | 2 | chr9q12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr18q12 | 5.98e-04 | 104 | 168 | 4 | chr18q12 | |
| Cytoband | 16q22.1 | 7.39e-04 | 110 | 168 | 4 | 16q22.1 | |
| Cytoband | 18q12 | 1.01e-03 | 13 | 168 | 2 | 18q12 | |
| GeneFamily | CD molecules|Mucins | 1.72e-11 | 21 | 103 | 7 | 648 | |
| GeneFamily | PHD finger proteins | 1.63e-04 | 90 | 103 | 5 | 88 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 1.91e-04 | 4 | 103 | 2 | 574 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 5.93e-04 | 181 | 103 | 6 | 694 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.12e-03 | 36 | 103 | 3 | 823 | |
| GeneFamily | Receptor Tyrosine Kinases|CD molecules | 1.52e-03 | 40 | 103 | 3 | 321 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 1.64e-03 | 41 | 103 | 3 | 1298 | |
| GeneFamily | Zinc fingers|Zinc fingers PARP-type|Poly(ADP-ribose) polymerases | 3.22e-03 | 15 | 103 | 2 | 26 | |
| GeneFamily | INO80 complex |SRCAP complex | 3.22e-03 | 15 | 103 | 2 | 595 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 4.20e-03 | 57 | 103 | 3 | 1179 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | RPGRIP1L ATG2B CKAP5 CNNM4 PPP1R10 KMT2C ZNF106 PHACTR4 NFAT5 | 2.22e-06 | 180 | 165 | 9 | M8239 |
| Coexpression | LIU_PROSTATE_CANCER_DN | KLF11 NHSL2 DTNA HLF LYST TGFBR3 GYPC EHF NAV2 MYOCD TNS4 MUC4 ICA1L | 1.56e-05 | 493 | 165 | 13 | M19391 |
| Coexpression | GSE19941_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_UP | 2.10e-05 | 182 | 165 | 8 | M8126 | |
| Coexpression | TESAR_ALK_AND_JAK_TARGETS_MOUSE_ES_D4_DN | 2.85e-05 | 10 | 165 | 3 | MM741 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#5_top-relative-expression-ranked_500 | 2.31e-06 | 149 | 163 | 9 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_500_k5 | |
| ToppCell | Tracheal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | ARHGAP32 CACNB4 SHROOM3 SH3RF1 FOXP2 PCLO MUC16 STRN CLMN EHF NPAS2 | 2.80e-10 | 200 | 167 | 11 | d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e |
| ToppCell | COVID-19-kidney-DCT|kidney / Disease (COVID-19 only), tissue and cell type | 4.06e-08 | 188 | 167 | 9 | df1fd0819d301679f3c9ea404e942e39095912eb | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 6.62e-08 | 199 | 167 | 9 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | BAL-Severe-cDC_4|Severe / Compartment, Disease Groups and Clusters | 1.53e-07 | 158 | 167 | 8 | 73f66689ef59f71b14cb7141ca5951cc47fe57c1 | |
| ToppCell | COPD-Epithelial|COPD / Disease state, Lineage and Cell class | 6.74e-07 | 192 | 167 | 8 | 0644fad5df18f0021f6f49cca996d8cf47f972ff | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D122|Adult / Lineage, Cell type, age group and donor | 6.74e-07 | 192 | 167 | 8 | 06013a07e3a873b1d1c0451643c528593ac32a9c | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Mucous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.17e-07 | 200 | 167 | 8 | c450a15e21fa72d071ed6e3b9f22de557a0f3cea | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Myocytic-Pericyte_3|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.35e-06 | 146 | 167 | 7 | 2ac9b487a7991fdc15444aeb93533030e09825bb | |
| ToppCell | NS-critical-d_0-4-Epithelial-unknown_epithelial|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.16e-06 | 166 | 167 | 7 | dd02bbe4af609c6348dc92417254f4740f2900a8 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.65e-06 | 176 | 167 | 7 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | CV-Severe-7|CV / Virus stimulation, Condition and Cluster | 4.65e-06 | 176 | 167 | 7 | 3de0c7d77210049e5616db21eed1490a17a5ec2d | |
| ToppCell | CV-Severe-7|Severe / Virus stimulation, Condition and Cluster | 4.83e-06 | 177 | 167 | 7 | 82fdd6185b368f54f03de389427cbe3071d21a99 | |
| ToppCell | droplet-Liver-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.83e-06 | 177 | 167 | 7 | 8ef41ee5d63737b810ad7371b0437625e7e1badf | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.20e-06 | 179 | 167 | 7 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | Control-Epithelial_cells-Airway_club|Control / group, cell type (main and fine annotations) | 5.59e-06 | 181 | 167 | 7 | c755d23dd9aabc717dc73e2b3fa99a1f751e6507 | |
| ToppCell | COVID-19-Heart-Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 6.23e-06 | 184 | 167 | 7 | 21790cdfa3b4036ad413fd44b94e31563116f25f | |
| ToppCell | COVID-19-Fibroblasts-Adventitial_FB|COVID-19 / group, cell type (main and fine annotations) | 6.45e-06 | 185 | 167 | 7 | a5aebf2b9b05b550d021272731d68af9a6b1229d | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.45e-06 | 185 | 167 | 7 | e58a009aaf342be019a909747b1895d5987d4daf | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.68e-06 | 186 | 167 | 7 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | COPD-Epithelial-Club|World / Disease state, Lineage and Cell class | 6.68e-06 | 186 | 167 | 7 | 3006f4ab1eaf1eb34c10ca9f7c869603d2d25744 | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-Treg_cell_3|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 6.68e-06 | 186 | 167 | 7 | 74eb69a52090f9e2426a47e03a1c478ee0cfec18 | |
| ToppCell | facs-Lung-18m-Epithelial-airway_epithelial-respiratory_basal_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.68e-06 | 190 | 167 | 7 | 47e07ea22733306d8885ee9e5f0b033e2f5e2afb | |
| ToppCell | facs-Lung-18m-Epithelial-airway_epithelial-respiratory_basal_cell-basal_epithelial_cell_of_bronchioalveolar_tree|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.68e-06 | 190 | 167 | 7 | 261b8afddfdcba4f70b50df126cef7ad00a0aae0 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.68e-06 | 190 | 167 | 7 | bf4511395fa97efd1c1cd17cc9bebb0271ee7f0e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.68e-06 | 190 | 167 | 7 | b6b8964b4910083499681b5fdf554e127b6a4c4e | |
| ToppCell | COPD-Epithelial-Club|COPD / Disease state, Lineage and Cell class | 7.95e-06 | 191 | 167 | 7 | c909cf5fa0e6519aa93a47d2c3fcd2ae2163cd8d | |
| ToppCell | PBMC-Severe-cDC_0|Severe / Compartment, Disease Groups and Clusters | 8.22e-06 | 192 | 167 | 7 | 4f4774b925058191673b4ba4b4d05b8b37f61795 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.22e-06 | 192 | 167 | 7 | cc9911e182a289779a2612bc213daae5607689e7 | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | 8.22e-06 | 192 | 167 | 7 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e | |
| ToppCell | LA-02._Fibroblast_II|LA / Chamber and Cluster_Paper | 8.80e-06 | 194 | 167 | 7 | 234d1494c114cce77c619708bbcd8d5ce805f19b | |
| ToppCell | RA-02._Fibroblast_II|RA / Chamber and Cluster_Paper | 9.09e-06 | 195 | 167 | 7 | 6a02ebbeb3199447ddce64d92d8809436e040eba | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.40e-06 | 196 | 167 | 7 | eea66711a16134f86e6c533a5a837ff2e0d7ca7f | |
| ToppCell | IPF-Epithelial|IPF / Disease state, Lineage and Cell class | 9.40e-06 | 196 | 167 | 7 | 87d9881cfec461a5d89b688a83749b618c519485 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_basal-Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.72e-06 | 197 | 167 | 7 | 1e915957ea6a4550ecb9d6ee4b232aa5800faf20 | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 1.00e-05 | 198 | 167 | 7 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.00e-05 | 198 | 167 | 7 | 2e2a4e1756bba6f4fbe529559a97d2993c890b4b | |
| ToppCell | Bronchial-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.04e-05 | 199 | 167 | 7 | 5f7da3eab58ace6cddb3179a415cd839d5767958 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.04e-05 | 199 | 167 | 7 | 3cd6383c50ce342fe5c175e2e50784d634a90e80 | |
| ToppCell | Tracheal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.07e-05 | 200 | 167 | 7 | c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.07e-05 | 200 | 167 | 7 | 0eb9ad8c0373bcc62029ec21c590ed03aaacd039 | |
| ToppCell | TCGA-Bladder-Solid_Tissue_Normal-Urothelial_normal_tissue-Urothelial_normal_tissue-2|TCGA-Bladder / Sample_Type by Project: Shred V9 | 1.55e-05 | 141 | 167 | 6 | 1baa054c2ae3b446d1954244b7fbf8af824ef345 | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.05e-05 | 159 | 167 | 6 | 24f87c666eff10c1844c900ffd7ad49fa9f80481 | |
| ToppCell | Mild-MAIT|Mild / Disease group and Cell class | 3.27e-05 | 161 | 167 | 6 | 0c1a04485708d5302600cdc2d7dac1cb76b4033a | |
| ToppCell | Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.63e-05 | 164 | 167 | 6 | e3983f655cdba308fb192182829f17bef99ce0ba | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | 3.88e-05 | 166 | 167 | 6 | 32d2eaf8a5d03881bf74d680825af2d5110b082d | |
| ToppCell | Control|World / group, cell type (main and fine annotations) | 4.15e-05 | 168 | 167 | 6 | a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.15e-05 | 168 | 167 | 6 | d60f7cd8269f373827f49c7785002cb38e4570a9 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.29e-05 | 169 | 167 | 6 | ccd98f9005aa0a88bd49f153be4e7200cc3dd0ac | |
| ToppCell | NS-critical-d_0-4-Epithelial-Secretory|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.29e-05 | 169 | 167 | 6 | aec97583b23112060437b619cb429dc32f29285f | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-Proximal_secretory_3|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 5.05e-05 | 174 | 167 | 6 | 9e5fae9ecc7c0111fc8a252e72b89dc89c0d3a7c | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.21e-05 | 175 | 167 | 6 | d8e385320f554d974538b7cdc4f8e4767f1455f2 | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.21e-05 | 175 | 167 | 6 | cf15465855602ba135752c18755e3e058dbd42ec | |
| ToppCell | Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.55e-05 | 177 | 167 | 6 | b59967219f7d874805768e247c0eb2bc4d4420c8 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.55e-05 | 177 | 167 | 6 | c9e8149639551a4c8daa90fcb2b895fdcff2e2ba | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-goblet-BEST2+_Goblet_cell|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.91e-05 | 179 | 167 | 6 | c833ded1f9e87be2ba2037820d92a389560b711c | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Megakaryocyte/Platelet|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.09e-05 | 180 | 167 | 6 | ca2a35bfb67347e47f511589a3d0f763e6664634 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.09e-05 | 180 | 167 | 6 | b798a3fa2dd15b68aa4267f665559527043dcc07 | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet-Megakaryocyte/Platelet_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.09e-05 | 180 | 167 | 6 | 4e9e8cde2919610c4ac0025b1c9819808048bc1d | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.09e-05 | 180 | 167 | 6 | 788d5fbf688365b5d92d3aa19b9f8e9448f8be5a | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.09e-05 | 180 | 167 | 6 | 466381bf93c3da6a2a241daadb68e9aad2964eae | |
| ToppCell | droplet-Liver-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.28e-05 | 181 | 167 | 6 | 4df7972f88117108698efd06b124b232f8588981 | |
| ToppCell | droplet-Liver-hepatocytes-3m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.28e-05 | 181 | 167 | 6 | cbb530566893281289026bfd93adf721decd4ca3 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.48e-05 | 182 | 167 | 6 | 17ed11a7ea366dd3106400511d5e628d3f1a9c3e | |
| ToppCell | E18.5-samps-Mesenchymal-Myofibroblast|E18.5-samps / Age Group, Lineage, Cell class and subclass | 6.68e-05 | 183 | 167 | 6 | de08f9ea02b7244d5a8788064631d10f06565337 | |
| ToppCell | facs-Lung-EPCAM-3m-Epithelial-Basal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.68e-05 | 183 | 167 | 6 | ecac1cfaff7553a60305b34d6cede6973ffb5430 | |
| ToppCell | facs-Lung-EPCAM-3m-Epithelial-respiratory_basal_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.68e-05 | 183 | 167 | 6 | f6ebfd7f61e912f92bd07313cc213a171747ac03 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4_RORB_CACNG5|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.88e-05 | 184 | 167 | 6 | 658f2e522055e88c92bc482a845c40f8f5f1a8e3 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-AT2_Progenitor|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.88e-05 | 184 | 167 | 6 | d0c212a8fbaad24597a84018442b25c61c17ea58 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.88e-05 | 184 | 167 | 6 | ab2f06906fc7a9931dfa0864ef506832b07fb93e | |
| ToppCell | Control-Epithelial_cells-Airway_goblet|Control / group, cell type (main and fine annotations) | 6.88e-05 | 184 | 167 | 6 | d92a71441e4e19f8c301999d8186f8e48e3cd162 | |
| ToppCell | (00)_Basal-(4)_1wkpi|(00)_Basal / shred by cell type and Timepoint | 7.09e-05 | 185 | 167 | 6 | bf82ba905e5eee1c39a2731702071d3de10a78b8 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.30e-05 | 186 | 167 | 6 | d65fa6d8e8a195ea10cfde1499d096d6acf7a634 | |
| ToppCell | Control-Epithelial-Club|World / Disease state, Lineage and Cell class | 7.30e-05 | 186 | 167 | 6 | 9798428691408e17ff2af2fe2d1b345f074d67e4 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.30e-05 | 186 | 167 | 6 | e83718fabb057100835d3357df407f283d23fe16 | |
| ToppCell | COVID-19-kidney-Mito-rich_Distal|kidney / Disease (COVID-19 only), tissue and cell type | 7.52e-05 | 187 | 167 | 6 | 2ce8038d9d1302e850c1bb536e755598f77ba4b9 | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-Treg_cell_3|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 7.52e-05 | 187 | 167 | 6 | 1eed2c1a05e80a7c8f639437c117afe0c18dfb0c | |
| ToppCell | COVID-19-Epithelial_cells|COVID-19 / group, cell type (main and fine annotations) | 7.75e-05 | 188 | 167 | 6 | c9cdee6f8d42ee69f5fb335f25084603c511bd29 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.75e-05 | 188 | 167 | 6 | 4bdf8d49af0e9da349b16e3f012e1b0eec04cc4f | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.75e-05 | 188 | 167 | 6 | 43a3a59f92ad93509d4166bd025aed0b1b39a008 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D175|Adult / Lineage, Cell type, age group and donor | 7.75e-05 | 188 | 167 | 6 | ec38def1fdbb34ed9b30244806975bd5a4370164 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.75e-05 | 188 | 167 | 6 | 4154f4787483c7e076e87a187733a9f666742c3d | |
| ToppCell | facs-Lung-EPCAM-18m-Epithelial-Basal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.98e-05 | 189 | 167 | 6 | 783c1db856f2defe6f3b8748dd0bc29a8102f6d1 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.98e-05 | 189 | 167 | 6 | 8ff3c3232eff9de4b5c9b22ecb82bc509d773f58 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.98e-05 | 189 | 167 | 6 | 90aae7e806882bebfad78a78e9a16cf56af3ecd4 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.98e-05 | 189 | 167 | 6 | c9565e962a13a7713056ec3dbb1b67d24f9889c7 | |
| ToppCell | IPF-Epithelial-Club|IPF / Disease state, Lineage and Cell class | 7.98e-05 | 189 | 167 | 6 | f3fcef008ef252b29ac6d567fef27f9acf9cd70f | |
| ToppCell | facs-Lung-EPCAM-18m-Epithelial-respiratory_basal_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.98e-05 | 189 | 167 | 6 | 88b72fafbe58463543e0818f27f3dd9e5b4d34d2 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.21e-05 | 190 | 167 | 6 | 30b50d183d7649146eb1e79b47ba897355f1998a | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 8.21e-05 | 190 | 167 | 6 | f1363f7806cfc4f14fbc1b0e8dac2de813a88eee | |
| ToppCell | IPF-Epithelial-Club|World / Disease state, Lineage and Cell class | 8.45e-05 | 191 | 167 | 6 | 3c88a6f1d74bb3b9173cd0ea3a63c6d9570e3954 | |
| ToppCell | 10x5'v1-week_17-19-Endothelial-stroma-proliferating_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 8.45e-05 | 191 | 167 | 6 | dc9e5eb6aa31b8d79aeec33e59b9138dfb469a3b | |
| ToppCell | Children_(3_yrs)-Epithelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.45e-05 | 191 | 167 | 6 | e432c6e1ae82dddf84314ce73d2b7a991630d905 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.45e-05 | 191 | 167 | 6 | b133ee1c0e58d00ddd2e4e05b01fd04947524c18 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.45e-05 | 191 | 167 | 6 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | Epithelial|World / Lineage, Cell type, age group and donor | 8.70e-05 | 192 | 167 | 6 | 499e8893afea5e6d3371e0bd018f7e86a524d669 | |
| ToppCell | Control-Epithelial-Club|Control / Disease state, Lineage and Cell class | 8.70e-05 | 192 | 167 | 6 | d84ed1ea4a03edaa18c804f75afb03bd7b1f0e16 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference|renal_papilla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 8.70e-05 | 192 | 167 | 6 | 6c106b91e46eabbe686a52a65a9c94ad9cbe9390 | |
| ToppCell | COVID-19-kidney-CNT|kidney / Disease (COVID-19 only), tissue and cell type | 8.70e-05 | 192 | 167 | 6 | d32ae226d95b4b6adb99d14b602be09b661d4cd9 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 8.95e-05 | 193 | 167 | 6 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | Epithelial-club_cell|World / Lineage, Cell type, age group and donor | 8.95e-05 | 193 | 167 | 6 | 2bdd09004fa433550958ec42ba4b06271a4aaf7c | |
| Drug | ICI 182,780; Down 200; 1uM; HL60; HT_HG-U133A | 1.03e-05 | 194 | 161 | 9 | 6165_DN | |
| Drug | Thioperamide maleate [106243-16-7]; Down 200; 9.8uM; MCF7; HT_HG-U133A | 1.07e-05 | 195 | 161 | 9 | 5270_DN | |
| Drug | Luteolin [491-70-3]; Down 200; 14uM; MCF7; HT_HG-U133A | 1.07e-05 | 195 | 161 | 9 | 5004_DN | |
| Drug | Spiramycin [8025-81-8]; Down 200; 4.8uM; PC3; HT_HG-U133A | 1.12e-05 | 196 | 161 | 9 | 3762_DN | |
| Drug | Amprolium hydrochloride [137-88-2]; Down 200; 12.6uM; PC3; HG-U133A | 1.16e-05 | 197 | 161 | 9 | 1898_DN | |
| Drug | SC 19220; Down 200; 10uM; PC3; HT_HG-U133A | 1.21e-05 | 198 | 161 | 9 | 7095_DN | |
| Drug | Harpagoside [19210-12-9]; Down 200; 8uM; PC3; HT_HG-U133A | 1.26e-05 | 199 | 161 | 9 | 6636_DN | |
| Drug | Letrozole [112809-51-5]; Down 200; 14uM; MCF7; HT_HG-U133A | 1.31e-05 | 200 | 161 | 9 | 7336_DN | |
| Drug | Trimethoprim [738-70-5]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 1.31e-05 | 200 | 161 | 9 | 4701_DN | |
| Drug | Resveratrol [501-36-0]; Down 200; 17.6uM; PC3; HT_HG-U133A | 6.19e-05 | 189 | 161 | 8 | 5084_DN | |
| Drug | Pramoxine hydrochloride [637-58-1]; Down 200; 12.2uM; PC3; HT_HG-U133A | 6.66e-05 | 191 | 161 | 8 | 3811_DN | |
| Drug | retinoic acid; Up 200; 1uM; PC3; HT_HG-U133A | 6.66e-05 | 191 | 161 | 8 | 1211_UP | |
| Drug | Phenacetin [62-44-2]; Down 200; 22.4uM; HL60; HT_HG-U133A | 6.91e-05 | 192 | 161 | 8 | 2471_DN | |
| Drug | ICI 182,780; Up 200; 0.01uM; MCF7; HT_HG-U133A_EA | 6.91e-05 | 192 | 161 | 8 | 1076_UP | |
| Drug | Norgestrel-(-)-D [797-63-7]; Up 200; 12.8uM; PC3; HT_HG-U133A | 7.43e-05 | 194 | 161 | 8 | 4269_UP | |
| Drug | Cephalothin sodium salt [58-71-9]; Down 200; 9.6uM; HL60; HT_HG-U133A | 7.70e-05 | 195 | 161 | 8 | 2517_DN | |
| Drug | Acyclovir [59277-89-3]; Up 200; 17.8uM; PC3; HT_HG-U133A | 7.98e-05 | 196 | 161 | 8 | 4683_UP | |
| Drug | Hydrochlorothiazide [58-93-5]; Down 200; 13.4uM; PC3; HG-U133A | 7.98e-05 | 196 | 161 | 8 | 1906_DN | |
| Drug | Acetopromazine maleate salt [3598-37-6]; Down 200; 9uM; PC3; HT_HG-U133A | 7.98e-05 | 196 | 161 | 8 | 4494_DN | |
| Drug | Doxazosin mesylate [77883-43-3]; Down 200; 7.4uM; MCF7; HT_HG-U133A | 8.27e-05 | 197 | 161 | 8 | 4988_DN | |
| Drug | Rimexolone [49697-38-3]; Up 200; 10.8uM; PC3; HT_HG-U133A | 8.27e-05 | 197 | 161 | 8 | 5092_UP | |
| Drug | Epitiostanol [2363-58-8]; Down 200; 13uM; MCF7; HT_HG-U133A | 8.27e-05 | 197 | 161 | 8 | 7342_DN | |
| Drug | Trioxsalen [3902-71-4]; Down 200; 17.6uM; MCF7; HT_HG-U133A | 8.27e-05 | 197 | 161 | 8 | 6078_DN | |
| Drug | Mimosine [500-44-7]; Up 200; 20.2uM; PC3; HT_HG-U133A | 8.27e-05 | 197 | 161 | 8 | 6703_UP | |
| Drug | Capsaicin [404-86-4]; Down 200; 13uM; MCF7; HT_HG-U133A | 8.27e-05 | 197 | 161 | 8 | 3372_DN | |
| Drug | Megestrol acetate [595-33-5]; Down 200; 10.4uM; MCF7; HT_HG-U133A | 8.57e-05 | 198 | 161 | 8 | 5013_DN | |
| Drug | Isoniazid [54-85-3]; Down 200; 29.2uM; MCF7; HT_HG-U133A | 8.57e-05 | 198 | 161 | 8 | 2246_DN | |
| Drug | Metanephrine hydrochloride DL [881-95-8]; Up 200; 17.2uM; MCF7; HT_HG-U133A | 8.57e-05 | 198 | 161 | 8 | 5334_UP | |
| Drug | Trimethobenzamide hydrochloride [554-92-7]; Down 200; 9.4uM; HL60; HG-U133A | 8.57e-05 | 198 | 161 | 8 | 2002_DN | |
| Drug | Mephenesin [59-47-2]; Up 200; 22uM; HL60; HT_HG-U133A | 8.57e-05 | 198 | 161 | 8 | 2342_UP | |
| Drug | Fenofibrate [49562-28-9]; Down 200; 11uM; MCF7; HT_HG-U133A | 8.57e-05 | 198 | 161 | 8 | 7474_DN | |
| Drug | vinblastine sulfate; Down 200; 0.1uM; PC3; HT_HG-U133A | 8.57e-05 | 198 | 161 | 8 | 7556_DN | |
| Drug | Ivermectin [70288-86-7]; Up 200; 4.6uM; PC3; HT_HG-U133A | 8.87e-05 | 199 | 161 | 8 | 5853_UP | |
| Drug | Ribavirin [36791-04-5]; Down 200; 16.4uM; PC3; HT_HG-U133A | 8.87e-05 | 199 | 161 | 8 | 7316_DN | |
| Drug | Gibberellic acid [77-06-5]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 8.87e-05 | 199 | 161 | 8 | 7330_DN | |
| Drug | Dinoprost trometamol [38362-01-5]; Down 200; 8.4uM; PC3; HT_HG-U133A | 8.87e-05 | 199 | 161 | 8 | 6308_DN | |
| Drug | Netilmicin sulfate [56931-57-2]; Up 200; 2.8uM; MCF7; HT_HG-U133A | 9.19e-05 | 200 | 161 | 8 | 6005_UP | |
| Drug | prochlorperazine dimaleate salt; Down 200; 10uM; MCF7; HT_HG-U133A | 9.19e-05 | 200 | 161 | 8 | 5212_DN | |
| Drug | AC1L1JLU | 9.76e-05 | 104 | 161 | 6 | CID000005098 | |
| Disease | colon cancer (implicated_via_orthology) | 2.73e-07 | 11 | 161 | 4 | DOID:219 (implicated_via_orthology) | |
| Disease | glucose measurement | ZAN LRRC37A3 COBLL1 ENTHD1 RFX6 GIGYF1 CRY2 LRRC37A MEGF8 GLI3 MANSC4 BSN | 1.30e-06 | 380 | 161 | 12 | EFO_0004468 |
| Disease | heart failure | 8.51e-06 | 185 | 161 | 8 | EFO_0003144 | |
| Disease | Thromboembolism | 3.38e-05 | 12 | 161 | 3 | C0040038 | |
| Disease | Myeloid Leukemia | 1.22e-04 | 18 | 161 | 3 | C0023470 | |
| Disease | Leukemia, Monocytic, Chronic | 1.22e-04 | 18 | 161 | 3 | C0023466 | |
| Disease | hypertrophic cardiomyopathy | 1.52e-04 | 92 | 161 | 5 | EFO_0000538 | |
| Disease | unipolar depression, bipolar disorder | 2.23e-04 | 156 | 161 | 6 | EFO_0003761, MONDO_0004985 | |
| Disease | QRS duration | 2.44e-04 | 298 | 161 | 8 | EFO_0005055 | |
| Disease | reaction time measurement | SH2B3 FOXP2 HLF LRRC37A2 HECTD4 APC PM20D1 CEP192 STRN DPEP2 N4BP2 NAV2 | 2.79e-04 | 658 | 161 | 12 | EFO_0008393 |
| Disease | non-arteritic anterior ischemic optic neuropathy (is_implicated_in) | 2.93e-04 | 5 | 161 | 2 | DOID:0050864 (is_implicated_in) | |
| Disease | mucinous adenocarcinoma (is_marker_for) | 2.93e-04 | 5 | 161 | 2 | DOID:3030 (is_marker_for) | |
| Disease | brain connectivity measurement | 3.69e-04 | 400 | 161 | 9 | EFO_0005210 | |
| Disease | cholangiocarcinoma (is_marker_for) | 4.20e-04 | 64 | 161 | 4 | DOID:4947 (is_marker_for) | |
| Disease | Myeloid Leukemia, Chronic | 5.25e-04 | 29 | 161 | 3 | C0023473 | |
| Disease | uric acid measurement | FAT4 SHROOM3 FLT4 COBLL1 HLF HECTD4 F5 HSF5 SETBP1 NFAT5 NPAS2 | 5.50e-04 | 610 | 161 | 11 | EFO_0004761 |
| Disease | diastolic blood pressure, unipolar depression | 5.81e-04 | 30 | 161 | 3 | EFO_0003761, EFO_0006336 | |
| Disease | platelet reactivity measurement, thrombus formation measurement | 6.10e-04 | 7 | 161 | 2 | EFO_0004985, EFO_0007615 | |
| Disease | stomach cancer (is_implicated_in) | 6.58e-04 | 72 | 161 | 4 | DOID:10534 (is_implicated_in) | |
| Disease | response to tyrosine kinase inhibitor | 8.11e-04 | 8 | 161 | 2 | EFO_0009170 | |
| Disease | cystic fibrosis, lung disease severity measurement | 1.04e-03 | 9 | 161 | 2 | EFO_0007744, MONDO_0009061 | |
| Disease | cortical surface area measurement | SHROOM3 ZBTB16 ZAN FOXP2 BAZ2B APC TRIOBP ZNF106 STRN RALBP1 GLI3 VCAN PKD1 NAV2 PRRT1 TCF7L1 AGAP3 | 1.13e-03 | 1345 | 161 | 17 | EFO_0010736 |
| Disease | neuroticism measurement, cognitive function measurement | 1.14e-03 | 566 | 161 | 10 | EFO_0007660, EFO_0008354 | |
| Disease | dipeptidase 2 measurement | 1.29e-03 | 10 | 161 | 2 | EFO_0801528 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 1.42e-03 | 222 | 161 | 6 | EFO_0008317, EFO_0020943 | |
| Disease | IGF-1 measurement | 1.50e-03 | 488 | 161 | 9 | EFO_0004627 | |
| Disease | systemic lupus erythematosus | SHROOM3 SLC6A16 C10orf67 HECTD4 ENTHD1 DDO MED1 LYST STAT4 EHF PRRT1 NOTCH2 | 1.51e-03 | 799 | 161 | 12 | MONDO_0007915 |
| Disease | cholesteryl esters to total lipids in small LDL percentage | 1.57e-03 | 42 | 161 | 3 | EFO_0022255 | |
| Disease | Semantic-Pragmatic Disorder | 1.58e-03 | 11 | 161 | 2 | C0454655 | |
| Disease | Auditory Processing Disorder, Central | 1.58e-03 | 11 | 161 | 2 | C0751257 | |
| Disease | forced expiratory volume, body mass index | 1.58e-03 | 11 | 161 | 2 | EFO_0004314, EFO_0004340 | |
| Disease | Language Delay | 1.58e-03 | 11 | 161 | 2 | C0023012 | |
| Disease | Language Development Disorders | 1.58e-03 | 11 | 161 | 2 | C0023014 | |
| Disease | Speech Delay | 1.58e-03 | 11 | 161 | 2 | C0241210 | |
| Disease | parental longevity | 1.63e-03 | 494 | 161 | 9 | EFO_0007796 | |
| Disease | intracranial aneurysm (is_implicated_in) | 1.88e-03 | 12 | 161 | 2 | DOID:10941 (is_implicated_in) | |
| Disease | QRS complex, QRS duration | 1.91e-03 | 45 | 161 | 3 | EFO_0005054, EFO_0005055 | |
| Disease | Thrombus | 2.04e-03 | 46 | 161 | 3 | C0087086 | |
| Disease | mean arterial pressure, alcohol drinking | 2.07e-03 | 98 | 161 | 4 | EFO_0004329, EFO_0006340 | |
| Disease | Ischemic stroke | 2.08e-03 | 324 | 161 | 7 | HP_0002140 | |
| Disease | low density lipoprotein cholesterol measurement, alcohol consumption measurement | 2.15e-03 | 99 | 161 | 4 | EFO_0004611, EFO_0007878 | |
| Disease | neuroimaging measurement | SHROOM3 ZBTB16 FOXP2 APC PM20D1 CREB1 ZNF106 STRN GLI3 VCAN PKD1 NAV2 ICA1L AGAP3 | 2.24e-03 | 1069 | 161 | 14 | EFO_0004346 |
| Disease | coronary artery disease | ARHGAP42 FAT4 SHROOM3 SH2B3 RGS19 HECTD4 PDXK R3HCC1L LPA RP1 MERTK BSN NFAT5 ICA1L MRTFA | 2.34e-03 | 1194 | 161 | 15 | EFO_0001645 |
| Disease | Malignant neoplasm of breast | VPS39 LRRC37A2 NUP98 DDO STAT4 CNNM4 LRRC37A PER2 ABRAXAS1 N4BP2 SETBP1 PRRT1 TCF7L1 NOTCH2 | 2.34e-03 | 1074 | 161 | 14 | C0006142 |
| Disease | Thrombosis | 2.44e-03 | 49 | 161 | 3 | C0040053 | |
| Disease | waist circumference | 2.55e-03 | 429 | 161 | 8 | EFO_0004342 | |
| Disease | precuneus cortex volume measurement | 2.58e-03 | 14 | 161 | 2 | EFO_0010326 | |
| Disease | cup-to-disc ratio measurement | 2.58e-03 | 430 | 161 | 8 | EFO_0006939 | |
| Disease | Leukemia, Myelocytic, Acute | 2.65e-03 | 173 | 161 | 5 | C0023467 | |
| Disease | platelet storage pool deficiency (implicated_via_orthology) | 2.97e-03 | 15 | 161 | 2 | DOID:2223 (implicated_via_orthology) | |
| Disease | Ischemic stroke, tissue plasminogen activator measurement | 2.97e-03 | 15 | 161 | 2 | EFO_0004791, HP_0002140 | |
| Disease | platelet component distribution width | FLT4 SH2B3 DBF4B COBLL1 HLF DDO BRD8 GSE1 TCF7L1 GP1BA NPAS2 | 2.98e-03 | 755 | 161 | 11 | EFO_0007984 |
| Disease | schizophrenia, intelligence, self reported educational attainment | 3.00e-03 | 346 | 161 | 7 | EFO_0004337, EFO_0004784, MONDO_0005090 | |
| Disease | peripheral arterial disease | 3.23e-03 | 54 | 161 | 3 | EFO_0004265 | |
| Disease | Acute Cerebrovascular Accidents | 3.23e-03 | 54 | 161 | 3 | C0751956 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 3.37e-03 | 264 | 161 | 6 | EFO_0008317, EFO_0020944 | |
| Disease | Ischemic stroke, plasminogen activator inhibitor 1 measurement | 3.38e-03 | 16 | 161 | 2 | EFO_0004792, HP_0002140 | |
| Disease | Seasonal Affective Disorder | 3.38e-03 | 16 | 161 | 2 | C0085159 | |
| Disease | Polyposis, Adenomatous Intestinal | 3.38e-03 | 16 | 161 | 2 | C2713442 | |
| Disease | Familial Intestinal Polyposis | 3.38e-03 | 16 | 161 | 2 | C2713443 | |
| Disease | Antithrombotic agent use measurement | 3.40e-03 | 55 | 161 | 3 | EFO_0009925 | |
| Disease | response to statin | 3.58e-03 | 56 | 161 | 3 | GO_0036273 | |
| Disease | Adenomatous Polyposis Coli | 3.81e-03 | 17 | 161 | 2 | C0032580 | |
| Disease | factor XI measurement, Ischemic stroke | 3.81e-03 | 17 | 161 | 2 | EFO_0004694, HP_0002140 | |
| Disease | lung disease severity measurement | 4.05e-03 | 118 | 161 | 4 | EFO_0007744 | |
| Disease | cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 4.42e-03 | 121 | 161 | 4 | EFO_0008595, EFO_0020943 | |
| Disease | Precursor Cell Lymphoblastic Leukemia Lymphoma | 4.55e-03 | 61 | 161 | 3 | C1961102 | |
| Disease | diet measurement, HOMA-B | 4.76e-03 | 19 | 161 | 2 | EFO_0004469, EFO_0008111 | |
| Disease | cytomegalovirus virus reactivation, response to allogeneic hematopoietic stem cell transplant | 4.76e-03 | 19 | 161 | 2 | EFO_0007044, EFO_0020106 | |
| Disease | anorectal malformation | 4.76e-03 | 19 | 161 | 2 | MONDO_0019938 | |
| Disease | Juvenile Myelomonocytic Leukemia | 4.76e-03 | 19 | 161 | 2 | C0349639 | |
| Disease | factor VIII measurement, Ischemic stroke | 4.76e-03 | 19 | 161 | 2 | EFO_0004630, HP_0002140 | |
| Disease | Cerebrovascular accident | 4.76e-03 | 62 | 161 | 3 | C0038454 | |
| Disease | celiac disease | 5.10e-03 | 126 | 161 | 4 | EFO_0001060 | |
| Disease | carcinoma (implicated_via_orthology) | 5.21e-03 | 64 | 161 | 3 | DOID:305 (implicated_via_orthology) | |
| Disease | triglycerides:total lipids ratio, intermediate density lipoprotein measurement | 5.25e-03 | 127 | 161 | 4 | EFO_0008595, EFO_0020947 | |
| Disease | Coronary Arteriosclerosis | 5.44e-03 | 65 | 161 | 3 | C0010054 | |
| Disease | Coronary Artery Disease | 5.44e-03 | 65 | 161 | 3 | C1956346 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MVEHTDIPEASPAST | 326 | Q6UWZ7 | |
| MQHPASGPAEVLSSS | 516 | Q96P47 | |
| MSLSPSSPRHEDQLE | 801 | Q86XL3 | |
| ATPSGDPSMEEHLSV | 136 | Q5SQH8 | |
| SDMVIIGESTSHVPP | 1246 | P13611 | |
| TEASPESMLSPSHGS | 576 | Q9H0E9 | |
| ESMLSPSHGSNPIED | 581 | Q9H0E9 | |
| HPFTNLTTLPSATMS | 2051 | Q8IZF6 | |
| TDHTLSVGAMPLPSS | 2136 | Q8IZF6 | |
| NLSTVSSAFPMVSHP | 61 | Q9UIF8 | |
| HEPKSPSLGMLSTAT | 6 | Q14687 | |
| TPEFSQSHMSATIPE | 3086 | Q6V0I7 | |
| PSEDQVLMSSAPTLH | 1101 | Q96L96 | |
| ATHTTSSTPMTPLLG | 401 | O00305 | |
| HQVPSSVSSPDDAMV | 806 | Q53SF7 | |
| SPTLFSMHPTTGVIT | 291 | Q02487 | |
| ADMDMSHSLSSLPPL | 411 | Q96BY7 | |
| AAFVTSPDPSALMSH | 566 | Q9ULK2 | |
| VDTPPGTSDEHMATI | 131 | Q9Y5Y2 | |
| DSIPATMGHISLSES | 306 | Q7Z5L2 | |
| ISMSEVASHGKPLPS | 946 | Q5TC82 | |
| MTECFLPPTSSPSEH | 1 | Q15311 | |
| SHGTSSREMVSSLPP | 901 | Q8HWS3 | |
| TLTVMDHGTPPLSTE | 421 | Q9Y5G8 | |
| TEMDNLRHTTPTASP | 786 | Q17RG1 | |
| SSHMLVTDSPSPEYL | 146 | Q99743 | |
| VNMTSGHSSAPPKET | 251 | Q6GTS8 | |
| SMSSPDLASPEKSAH | 421 | Q8IYW4 | |
| PMSTPSHELSKSEAD | 1491 | Q8WXI7 | |
| ITSGPDINSAPMTHS | 1951 | Q8WXI7 | |
| ATSPLVTSHIMGDIT | 4271 | Q8WXI7 | |
| VPADSHTSKATSPMG | 5736 | Q8WXI7 | |
| HIPDSDQSTMSPDII | 9921 | Q8WXI7 | |
| LGEPETTPSMATSHG | 10956 | Q8WXI7 | |
| SEPETTPSMATSHGV | 11121 | Q8WXI7 | |
| HSELDTMPSTVTSPE | 11286 | Q8WXI7 | |
| SHRGSDTAPSMVTSP | 11596 | Q8WXI7 | |
| LTHSPGMPETTALLS | 11761 | Q8WXI7 | |
| GMPETTALLSTHPRT | 11766 | Q8WXI7 | |
| TPDTSTMHLATSRTP | 13451 | Q8WXI7 | |
| STAMHTRSTAAPIPI | 4296 | Q99102 | |
| TLKATGSTHTAPPMT | 2051 | Q6W4X9 | |
| SPHTYVSDTTSSPMI | 2156 | Q04721 | |
| LPMTAASHSSAFTPV | 876 | Q9Y4B6 | |
| SMPEDQEPVSASTHI | 966 | P52948 | |
| PESSMESLTLPNHEV | 266 | O60309 | |
| LHMTSALSSSPTYPD | 156 | P10071 | |
| SSAPDVPSMGLVSSH | 4116 | Q8NEZ4 | |
| HTLSATGSLDVPMAV | 911 | O75420 | |
| PESSMESLTLPNHEV | 266 | A6NM11 | |
| PESSMESLTLPNHEV | 266 | A6NMS7 | |
| HLGTMLSPASSQTAP | 771 | Q6P4R8 | |
| VESLTPSSLSLMHSP | 1106 | Q16706 | |
| SFVDIMPHQSDETSP | 976 | Q68CZ1 | |
| HSSMLPLGSSLPDEL | 971 | Q12866 | |
| LAVSLDAPPSTSTMD | 926 | Q9UPZ3 | |
| QPSHSDMTTPLGLSR | 116 | Q96Q04 | |
| MVHASASTSPLCSPT | 1571 | Q9UPA5 | |
| ALMSVADTLGTAHSP | 626 | Q9H1B7 | |
| FPSHPTLTSEMASAS | 931 | O15055 | |
| SPSHTAIPAGMEADL | 31 | Q9Y6V0 | |
| RENAPMTLTTSPHDT | 71 | Q02505 | |
| TVMEPHTESLNPGSS | 1651 | Q14999 | |
| PMSLVTTANHSPELE | 686 | O15409 | |
| SASVGPPMEESVAHA | 1831 | Q7Z7M0 | |
| SSAEMPHTETVSPLP | 41 | Q9H9S0 | |
| PHTETVSPLPSSMDL | 46 | Q9H9S0 | |
| ATPTHTDITPMDPSF | 896 | Q8IZD2 | |
| MHFENISSPESSPEI | 946 | Q8IZD2 | |
| GMLPSTEAPSSTTHQ | 166 | A6NHS7 | |
| LAMSHASGVKTSPDP | 121 | Q1ED39 | |
| PSVMDLSSRASAPLH | 121 | Q16534 | |
| SLPSPAMTLSSAIDS | 76 | Q96A73 | |
| LPIGSTMSTVHLSSD | 6 | Q9Y4D8 | |
| ALMSPHSAEDVDLSP | 771 | A7KAX9 | |
| VSPGMFSSTEPTVHT | 841 | O94916 | |
| TNTTATPSLTHMVPA | 241 | Q8IZ21 | |
| PSPVHVCTEESLMSS | 486 | Q8IZQ8 | |
| DTTSDVAAGMLIPHT | 41 | Q99489 | |
| HTSLGSPVSSDPVHM | 156 | Q9NQX5 | |
| PAVPTVASSTDMLHS | 1966 | Q14008 | |
| DVTAVPMSPSSHSPE | 361 | Q969S8 | |
| HPVAEPSSSQAGSMS | 531 | Q49AN0 | |
| GASSHITTKSMAAPP | 426 | P56159 | |
| MAHPSETSPLKGASE | 36 | I3L273 | |
| MGPPASHTCVSATTL | 416 | Q8NFT6 | |
| SHPTEGSPVTLTCKM | 26 | Q96LA6 | |
| ISMTTTSHLPVAESP | 171 | Q9NZC4 | |
| MADHNPDSDSTPRTL | 1 | Q96BT3 | |
| TAHVMPSTLGTSPAK | 91 | Q6P2H3 | |
| TVVPVPSMEAHSEAA | 1591 | P08519 | |
| PSMEAHSEAAPTEQT | 1596 | P08519 | |
| MPAAHATSSAPTVTL | 41 | P16220 | |
| STASEPLSHMLPCIS | 931 | Q99698 | |
| TASLDSQMPSSLHPT | 331 | P07359 | |
| TPIPSSTVHSSVADM | 1226 | Q8TEP8 | |
| PVTSMNDTLFSHSVP | 341 | Q9Y4J8 | |
| LSMPASVSLPVEASH | 571 | Q53TQ3 | |
| AHTMPGTYAPSTTLS | 51 | Q9H4A9 | |
| SVSESSPHMAPVLAV | 461 | Q9H4A9 | |
| SPSAVHMDAVEPTTP | 426 | Q9NWQ4 | |
| VTTTVHMDAATPELP | 81 | O14901 | |
| VSAHSGMNTPSVEPS | 441 | Q9UK59 | |
| STTMHTTTIAEPDPG | 26 | P04921 | |
| SQEPSMGSEPLAHSS | 381 | Q8NDH6 | |
| MSSEKSGLPDSVPHT | 1 | Q99946 | |
| MLELETGLHVTPSPS | 1046 | Q9Y2H2 | |
| VMDTEHSNPPDSGSS | 91 | Q9Y467 | |
| EEPMDTSPSGLHSKL | 516 | Q9NVU0 | |
| PTHLSLVDSAQASPM | 571 | Q5VV67 | |
| PSASPLPVVTDHAMT | 981 | Q8NG08 | |
| VNMTADTLDTPHITP | 726 | Q15648 | |
| MSAGTLLTAHSPTPV | 156 | A1KXE4 | |
| SSATSPISHLPGSLM | 41 | Q969Z0 | |
| EPEALHTPTLMTTPS | 211 | P15407 | |
| VSSPAPTQDTHMETD | 3481 | P98161 | |
| HMETDLLSSLSSTPG | 3491 | P98161 | |
| MSDTPSTGFSIIHPT | 1 | P56715 | |
| LTSMPVRHTPVASSE | 1221 | Q685J3 | |
| GMTPLTSTPVSHTLV | 1806 | Q685J3 | |
| SETSTPLTSMPVNHT | 2806 | Q685J3 | |
| RENAPMTLTTSPHDT | 71 | Q9H195 | |
| SMKISHTSPDIPLST | 126 | Q86SS6 | |
| PTHMDALSSCVTPTA | 316 | Q4G112 | |
| EADRPPSMSSHDTAS | 16 | P49795 | |
| IPASVDLVSSDPSHM | 616 | O43815 | |
| TPSEGMTHSSVLPSQ | 426 | O60279 | |
| PMTASTSLPLSHQLT | 696 | Q9GZN6 | |
| ETTPTDIHPDSMLNV | 651 | Q96DN5 | |
| FPTDISQMSPSSEHE | 1166 | P12259 | |
| PELSHMTLSPELSQT | 1296 | P12259 | |
| TPTPTVSMSLTLGHL | 721 | Q5HYW2 | |
| PDSTPMGSIESLSSH | 626 | A6NI28 | |
| SSAEMPHTETVSPLP | 41 | Q6NSW7 | |
| PHTETVSPLPSSMDL | 46 | Q6NSW7 | |
| GSLPLTPRMESHSED | 41 | Q96MH2 | |
| AMSTLGSSSSQPHPE | 886 | O14594 | |
| KASDHMPESLLASSP | 876 | Q8IWB4 | |
| GTIMDPHSPESLSVD | 971 | P58107 | |
| SSHPGMSDNAPASLE | 341 | Q8IVL1 | |
| ESTPPSFMSVHAQLA | 1611 | Q8TF72 | |
| TLHPTSEELTIAGMT | 56 | Q9NR31 | |
| GITNTSMSHESPVLP | 531 | Q6ZUB0 | |
| AMEGPTPVSALLHSS | 236 | P03915 | |
| MDTSELHFVPEPSST | 861 | Q969V6 | |
| MSRPIPSHLTSAVAE | 476 | O94818 | |
| HSMGPDTVVITSSDL | 176 | O00764 | |
| MESLAPSTDSLHGSP | 1196 | Q9H2D6 | |
| RHSMEISPPVLISSS | 321 | Q7Z6J0 | |
| LMPGSATHTAAISIS | 636 | Q7Z6J0 | |
| PSLPDMSLSTHSSVQ | 2486 | P25054 | |
| ESHSLSPPGENTVMA | 521 | Q96JQ2 | |
| LFHTSPTEMTEETTP | 291 | Q6ZU45 | |
| PSTTALRPHSATMSV | 366 | Q8IYJ2 | |
| TMALTSVPSDRSPAH | 641 | Q6P4Q7 | |
| RAHSSLSSTMCPSPE | 31 | Q96SZ6 | |
| GSLTPTESIMSLGTH | 536 | Q9UPV9 | |
| KASDHMPESLLASSP | 876 | Q5VYP0 | |
| GITNTSMSHESPVLP | 531 | P0C874 | |
| HTESSPVSAVNMETP | 526 | Q14592 | |
| FDAPEMDHLPTTTAT | 281 | Q9Y548 | |
| LSMPSSVTSGLHVQP | 346 | Q05516 | |
| AVIPMDSDSPVHSTV | 101 | Q8NDY8 | |
| PSLSDSMPSVADSHS | 711 | Q9NV58 | |
| KASDHMPESLLASSP | 876 | Q5TZJ5 | |
| KASDHMPESLLASSP | 876 | Q5VU36 | |
| DSPASSHGSMLDSPA | 466 | Q9HCS4 | |
| SHGSMLDSPATPSAA | 471 | Q9HCS4 | |
| EHASSCPPSITNSMV | 356 | Q8IZW8 | |
| SDSTEPHSPSDLLPM | 706 | Q14765 | |
| PSDLHPTMTAALISN | 481 | O94759 | |
| LQAHMVAEISPSSSP | 71 | Q99469 | |
| SMTPPTLNITEESHV | 26 | P35916 | |
| TEPTPEMSSLPVRSH | 16 | Q8N8P6 | |
| EMHIPSALEPSTSSS | 316 | Q9UQQ2 | |
| SDTSSAIIPSTHMPD | 181 | Q7L804 | |
| PASESCPPESDTHMT | 456 | Q96RU2 | |
| CPPESDTHMTLPLSS | 461 | Q96RU2 | |
| MDLPIQDSHDSSTSP | 1 | Q8N7R0 | |
| MAALHTTPDSPAAQL | 1 | A6NFI3 | |
| SIPLTRPAHSTSVSM | 501 | Q9UPP1 | |
| TLHPTSEELTIAGMT | 56 | Q9Y6B6 | |
| AMPSLTTSHLQTVPS | 691 | O15016 | |
| QSLVASSPAAMHPLS | 766 | Q9Y6X0 | |
| TSIMGSPNSHPSEEL | 586 | Q96QC0 | |
| LHLTSPITMGTEPAT | 16 | Q7Z2V1 | |
| QSEALAPDSMSHPRS | 761 | Q6BDS2 | |
| ESELQMTSAASPHPG | 651 | Q9H2Y7 | |
| HFSSPTSPMLDESVI | 646 | P45974 | |
| SPVSASHPVQALMES | 31 | Q03167 | |
| HQSSTSPLMEGTPTI | 436 | Q96JC1 | |
| SPTATGLAALVMSPH | 1006 | Q9Y493 | |
| TTMHPTTASPETPEL | 191 | Q8TEU8 | |
| VTSAISTELDPHGMS | 256 | Q8N8K9 | |
| STELDPHGMSASPSV | 261 | Q8N8K9 | |
| PDTTHLPASMTSSGV | 646 | Q9UKN1 | |
| ASGLLEASMPVHSST | 741 | Q9UKN1 | |
| PGSTQTMHFPESDTT | 836 | Q9UKN1 | |
| PGSTQTMHFPESDTT | 3476 | Q9UKN1 | |
| PENHESMTSIFPSAA | 1211 | Q86UW6 |